Sanofi develops cut-price Indian insulin device for emerging markets
This article was originally published in Scrip
Executive Summary
Sanofi India has launched AllStar, the first indigenously-manufactured, reusable insulin pen from a multinational company in the country and the first such cut-price device made outside of the French multinational's facility in Frankfurt, Germany.